O-023FOLFOX/bevacizumab +/- irinotecan in advanced colorectal cancer (CHARTA): Long term outcome. (20th June 2018) - Schmoll, H; Garlipp, B; Junghanß, C; Vogel, A; Kaiser, U; Florschütz, A; Kanzler, S; Hannig, C; Meinert, F; Cygon, F; Stein, A